AlphaHunt
Healthcare

WST Stock Analysis

West Pharmaceutical Services, Inc. · current price $323.24 (-1.89% today)

★★★★★ Top Tier 72/ Alpha Score
Top-tier setup — 21% revenue growth, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
LAST EARNINGS West Pharmaceutical Services, Inc. (WST)

Latest earnings

EPS
$1.84 vs $1.54 est · +0.2% vs estimate BEAT
Revenue
$844.9M · +10.2% YoY
Stock reaction (1M)
+6.4%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
72/100
Grade
A
Rev Growth YoY
+21.0%
30-day Momentum
+6.4%
Forward P/E
43.3×
Analyst Target
$358.79
Implied Upside
+11.0%

Latest news on WST

Similar stocks in Healthcare

BIIB LLY WAT MRNA HOLX DGX

View all Healthcare stocks →

WST — frequently asked

What is WST's Alpha Score?

West Pharmaceutical Services, Inc. (WST) currently has a TickerMover Alpha Score of 72/100, rated ★★★★★ Top Tier. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is West Pharmaceutical Services, Inc. (WST) a buy?

TickerMover does not give buy or sell recommendations. WST scores 72/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is WST's score updated?

WST's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for WST →